Hong Kong-listed Chinese biotech firm Jacobio Pharma says it hopes to commercialize a new drug that it's developing with AstraZeneca. Speaking on Bloomberg's "The China Show," the company's Co-CEO, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback